Popular Articles

Amira Pharmaceuticals Announces Initial Positive Phase 1 Clinical Data For AM211, A Novel Product Candidate For The Treatment Of Respiratory Diseases
Amira Pharmaceuticals, Inc. announced initial positive data from a Phase 1 clinical study of AM211, the company"s oral selective antagonist of the DP2 (also known as CRTH2) receptor.
buy viagra
Do The Swiss Have The Answer To America's Health Care Dilemma?
With the health care debate heating up in Washington, and with no apparent solution in sight, it has been suggested that America might want to take a page from the Swiss playbook.
plan for health
News of the day
Journal For The Sociçİtçİ De Pathologie Exotique To Be Published And Distributed By Springer
As of January 2010, the Bulletin de la Sociçİtçİ de Pathologie Exotique will join Springer"s publishing program. Founded in 1908 by Nobel Laureate Louis-Alphonse Laveran, the society celebrated its centenary last year. It plays a major role in the promotion of health issues and information on tropical pathology.
Cardiovascular

Interest Groups Crowd Airwaves, Pursue Lawmakers

"The increasingly heated fight over health-care legislation is saturating the summer airwaves, with groups on all sides of the debate pouring tens of millions of dollars into advertising campaigns designed to push the cause of reform forward, slow it down or stop it in its tracks," the Washington Post reports. So far, drug makers, labor groups, Democrats and Republicans - among others - have spent $52 million to finance the ad campaigns, a heady start that could lead to a "record-breaking legislative battle." "Much of the spending has been focused on national cable news and the local Washington market, the best way to reach policymakers and opinion leaders in the capital. But as members of Congress leave for August recess, advertising money will follow them, as the target audience for health-care messages shifts from inside to outside the Beltway," the Post reports (Pershing, 8/5). The many interest groups that could gain or lose from have heated up lobbying campaigns both on and off the air, as the August recess is seen as the time to deliver messages. The Wall Street Journal reports on a few samples: "If you"re looking for savings, don"t come at us," said Tim Trysla, a senior medical device industry representative; "Attacking our community will not help get anyone covered," said Karen Ignagni, chief executive of lobbying group America"s Health Insurance Plans. Insurers have recently come under fire from Democrats. "What has fueled the lobbying surge is that President Barack Obama has left the details of the health overhaul to Congress. That means interest groups have plenty of decision-makers to badger. It also makes any legislation vulnerable to death by a thousand cuts," the Journal reports. For instance, lobbyists have successfully deterred Senators from a plan to tax health benefits, and a small hospital succeeded delaying action in the House (Adamy and Williamson, 8/5). This information was reprinted from kaiserhealthnews.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives and sign up for email delivery at kaiserhealthnews.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):